These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 10585173

  • 1. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD, Nauert C, Stehle B.
    Maturitas; 1999 Sep 24; 33(1):45-58. PubMed ID: 10585173
    [Abstract] [Full Text] [Related]

  • 2. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD, Ehrly AM, Kuhl H.
    Arzneimittelforschung; 1997 Jun 24; 47(6):761-7. PubMed ID: 9239456
    [Abstract] [Full Text] [Related]

  • 3. Comparative bioequivalence studies with Estradot and Menorest transdermal systems.
    Hossain M, Quebe-Fehling E, Sergejew T, Schmidt G, Skerjanec A, Cohen A, Krinsky L, Ibarra de Palacios P.
    Maturitas; 2003 Nov 20; 46(3):187-98. PubMed ID: 14585521
    [Abstract] [Full Text] [Related]

  • 4. Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
    Andersson TL, Stehle B, Davidsson B, Höglund P.
    Maturitas; 2000 Jan 15; 34(1):57-64. PubMed ID: 10687883
    [Abstract] [Full Text] [Related]

  • 5. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: experimental results.
    Rohr UD, Saeger-Lorenz K.
    J Pharm Sci; 2002 Mar 15; 91(3):810-21. PubMed ID: 11920767
    [Abstract] [Full Text] [Related]

  • 6. Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.
    Reginster JY, Albert A, Deroisy R, Colette J, Vrijens B, Blacker C, Brion N, Caulin F, Mayolle C, Regnard A, Scholler R, Franchimont P.
    Maturitas; 1997 Jun 15; 27(2):179-86. PubMed ID: 9255753
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch.
    Bacchi-Modena A, Bolis P, Campagnoli C, De Cicco F, Meschia M, Pansini F, Pisati R, Hüls G.
    Maturitas; 1997 Jul 15; 27(3):285-92. PubMed ID: 9288701
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar 15; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 9. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: theoretical predictions with an oscillating diffusion coefficient model.
    Rohr UD, Saeger-Lorenz K.
    J Pharm Sci; 2002 Mar 15; 91(3):822-44. PubMed ID: 11920768
    [Abstract] [Full Text] [Related]

  • 10. Comparison of pharmacokinetic profiles of a 17 beta-estradiol gel 0.6 mg/g (Gelestra) with a transdermal delivery system (Estraderm TTS 50) in postmenopausal women at steady state.
    Paoletti AM, Pilia I, Nannipieri F, Bigini C, Melis GB.
    Maturitas; 2001 Dec 14; 40(3):203-9. PubMed ID: 11731181
    [Abstract] [Full Text] [Related]

  • 11. Menorest: technical development and pharmacokinetic profile.
    Marty JP.
    Eur J Obstet Gynecol Reprod Biol; 1996 Apr 14; 64 Suppl():S29-33. PubMed ID: 8732471
    [Abstract] [Full Text] [Related]

  • 12. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS, Donath F, Blume HH.
    Int J Clin Pharmacol Ther; 2012 Feb 14; 50(2):100-17. PubMed ID: 22257576
    [Abstract] [Full Text] [Related]

  • 13. New trends in transdermal technologies: development of the skin patch, Menorest.
    Marty JP.
    Int J Gynaecol Obstet; 1996 Mar 14; 52 Suppl 1():S17-20. PubMed ID: 8666122
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.
    Pornel B, Genazzani AR, Costes D, Dain MP, Lelann L, Vandepol C.
    Maturitas; 1995 Nov 14; 22(3):207-18. PubMed ID: 8746878
    [Abstract] [Full Text] [Related]

  • 15. Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches.
    Reginster JY, Donazzolo Y, Brion N, Lins R.
    Climacteric; 2000 Sep 14; 3(3):168-75. PubMed ID: 11910618
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of weekly transdermal estradiol controlled delivery system in postmenopausal Chinese.
    Chen GS, Zhang MY, Wang Q, Ye JC.
    Zhongguo Yao Li Xue Bao; 1996 Sep 14; 17(5):407-10. PubMed ID: 9863160
    [Abstract] [Full Text] [Related]

  • 17. Bioavailability of estradiol from two transdermal patches.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Mar 14; 46(3):307-10. PubMed ID: 8901155
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the local tolerability and adhesion of a new matrix system (Menorest) for estradiol delivery with an established transdermal membrane system (Estraderm TTS).
    Erianne JA, Winter L.
    Maturitas; 1997 Mar 14; 26(2):95-101. PubMed ID: 9089558
    [Abstract] [Full Text] [Related]

  • 19. Bioavailability of norethisterone acetate alone and in combination with estradiol administered in single or multiple oral doses to postmenopausal women.
    Stadberg E, Westlund P, Landgren BM, Aedo AR, Cekan SZ, Mattsson LA.
    Maturitas; 1999 Sep 24; 33(1):59-69. PubMed ID: 10585174
    [Abstract] [Full Text] [Related]

  • 20. Plasma concentration of estradiol following transdermal administration of Systen 50 or Menorest 50.
    Reginster JY, Albert A, Deroisy R, Colette J, Vrijens B, Blacker C, Brion N, Caulin F, Mayolle C, Regnard A, Sholler R, Franchimont P.
    Scand J Rheumatol Suppl; 1996 Sep 24; 103():94-8; discussion 99-100. PubMed ID: 8966499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.